Healthcare provider profile · identity verified

Megan Chartier, NP

Nurse Practitioner · SOUTH HADLEY, MA · NPI 1154750719

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	545	147
Amlodipine Besylate	Amlodipine Besylate	511	127
Levothyroxine Sodium	Levothyroxine Sodium	300	65
Omeprazole	Omeprazole	228	66
Lisinopril	Lisinopril	225	56
Gabapentin	Gabapentin	183	34
Metoprolol Succinate	Metoprolol Succinate	182	46
Eliquis	Apixaban	180	37
Pravastatin Sodium	Pravastatin Sodium	180	42
Fluticasone Propionate	Fluticasone Propionate	172	66
Furosemide	Furosemide	138	32
Famotidine	Famotidine	135	36
Albuterol Sulfate Hfa	Albuterol Sulfate	134	48
Metformin Hcl	Metformin Hcl	124	31
Losartan Potassium	Losartan Potassium	118	35
Ozempic	Semaglutide	116	22
Simvastatin	Simvastatin	112	26
Fluoxetine Hcl	Fluoxetine Hcl	109	29
Sertraline Hcl	Sertraline Hcl	100	25
Rosuvastatin Calcium	Rosuvastatin Calcium	97	24
Hydrochlorothiazide	Hydrochlorothiazide	95	26
Lorazepam	Lorazepam	94	17
Pantoprazole Sodium	Pantoprazole Sodium	91	25
Oxycodone Hcl	Oxycodone Hcl	90	11
Duloxetine Hcl	Duloxetine Hcl	86	23
Ezetimibe	Ezetimibe	85	25
Carvedilol	Carvedilol	84	24
Zolpidem Tartrate	Zolpidem Tartrate	84	16
Tramadol Hcl	Tramadol Hcl	81	19
Allopurinol	Allopurinol	74	16
Montelukast Sodium	Montelukast Sodium	74	19
Venlafaxine Hcl Er	Venlafaxine Hcl	72	14
Trazodone Hcl	Trazodone Hcl	71	21
Trulicity	Dulaglutide	71	11
Bupropion Xl	Bupropion Hcl	69	20
Atenolol	Atenolol	67	17
Metformin Hcl Er	Metformin Hcl	67	20
Valsartan	Valsartan	66	14
Farxiga	Dapagliflozin Propanediol	61	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	59	11
Alendronate Sodium	Alendronate Sodium	58	21
Metoprolol Tartrate	Metoprolol Tartrate	56	20
Clopidogrel	Clopidogrel Bisulfate	47	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	45	13
Tamsulosin Hcl	Tamsulosin Hcl	45	12
Clonazepam	Clonazepam	44	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	44	12
Escitalopram Oxalate	Escitalopram Oxalate	43	17
Quetiapine Fumarate	Quetiapine Fumarate	42	11
Spironolactone	Spironolactone	42	13
Alprazolam	Alprazolam	37	suppressed
Buspirone Hcl	Buspirone Hcl	37	suppressed
Celecoxib	Celecoxib	37	suppressed
Synthroid	Levothyroxine Sodium	37	suppressed
Topiramate	Topiramate	35	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	34	suppressed
Mirtazapine	Mirtazapine	34	12
Breo Ellipta	Fluticasone/Vilanterol	32	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	suppressed
Glipizide Er	Glipizide	30	suppressed
Nifedipine Er	Nifedipine	30	suppressed
Lamotrigine	Lamotrigine	29	suppressed
Fenofibrate	Fenofibrate	28	suppressed
Humalog Kwikpen U-100	Insulin Lispro	26	suppressed
Jardiance	Empagliflozin	26	suppressed
Tresiba Flextouch U-200	Insulin Degludec	26	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Digoxin	Digoxin	25	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Pregabalin	Pregabalin	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	23
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Prednisone	Prednisone	23	22
Glimepiride	Glimepiride	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Baclofen	Baclofen	21	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	19
Ibuprofen	Ibuprofen	20	suppressed
Irbesartan	Irbesartan	20	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Clonidine	Clonidine	19	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Ipratropium Bromide	Ipratropium Bromide	19	12
Novolog Flexpen	Insulin Aspart	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	19	suppressed
Aripiprazole	Aripiprazole	18	suppressed
Midodrine Hcl	Midodrine Hcl	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	17	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Diazepam	Diazepam	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Methimazole	Methimazole	14	suppressed
Azithromycin	Azithromycin	13	13
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Galantamine Hbr	Galantamine Hbr	13	suppressed
Glipizide	Glipizide	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Atrovent Hfa	Ipratropium Bromide	12	suppressed
Cevimeline Hcl	Cevimeline Hcl	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Veozah	Fezolinetant	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error